Merrimack Pharmaceuticals Inc. (MACK) Jumps 6.69% on January 14

Equities Staff |

Merrimack Pharmaceuticals Inc. (MACK) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 6.69% to $6.38, representing a gain of $0.4 per share. Some 1.22 million shares traded hands on 9,140 trades, compared with an average daily volume of 1.47 million shares out of a total float of 115.57 million. The stock opened at $6.17 and traded with an intraday range of $6.41 to $5.98.

After today's gains, Merrimack Pharmaceuticals Inc. reached a market cap of $737.36 million. Merrimack Pharmaceuticals Inc. has had a trading range between $13.84 and $5.79 over the last year, and it had a 50-day SMA of $8.37 and a 200-day SMA of $10.32.

Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.

Merrimack Pharmaceuticals Inc. is based out of Cambridge, MA and has some 306 employees. Its CEO is Robert J. Mulroy.

For a complete fundamental analysis analysis of Merrimack Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for MACK. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…